Cloxin

Quick links to important sections

Cloxin

Method of action: Bactericidal

Treatment option: Abscess

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cloxin

Quick Facts

Property Description
Active ingredient Cloxacillin (Sodium salt)
Form Capsule, Oral Solution, Injectable
Pharmacological class Antibiotic (Penicillinase-resistant)
Common use Resolving bacterial infections
Origin Semi-synthetic

Cloxin: Definition and Pharmacological Classification

Cloxin is a medication containing the active component Cloxacillin, which is fundamentally classified as an antibiotic (beta-lactam antibacterial agent). Cloxacillin is a semi-synthetic penicillin, meaning its chemical structure is designed to improve upon the effectiveness of the naturally occurring penicillin molecule. It is classified as a penicillinase-resistant penicillin, a crucial attribute that defines its clinical utility against drug-resistant bacteria.

This classification recognizes its specific role against bacterial strains that utilize the defense enzyme beta-lactamase (penicillinase). Cloxacillin is designed to remain potent even against bacteria that try to chemically destroy the drug.


Composition, Forms, and Origin

Cloxin is manufactured as a single-ingredient product, containing only Cloxacillin, typically administered as the Cloxacillin Sodium Monohydrate salt. The drug is clinically recognized for its acid stability, which allows for reliable oral absorption, a key feature differentiating it from older penicillin derivatives.

The medication is available for several routes of administration, including hard capsules and a powder for oral solution intended for oral use, and sterile preparations for parenteral (intravenous or intramuscular) administration. Cloxacillin is classified as a systemic antibacterial agent. The availability of the liquid oral solution distinguishes it for patient groups who may have difficulty swallowing the hard capsules, providing broader patient access.


General Purpose and Unique Benefit

The overall purpose of Cloxin is the effective elimination of bacterial infections throughout the body, achieved through a bactericidal action that actively kills the pathogenic organisms. The primary benefit lies in its ability to remain potent against certain bacteria, particularly susceptible staphylococcal infections. Because Cloxacillin resists the enzymatic defenses of these pathogens, it serves as a reliable agent for controlling and resolving these targeted bacterial threats.

What side effects are possible with Cloxin?

Possible Side Effects and Safety Information

Adverse Reaction Profile

Cloxin (cloxacillin) is associated with adverse reactions primarily involving the Gastrointestinal, Immunologic, Hepato-biliary, and Hematologic systems.

Common reactions include nausea, vomiting, diarrhea, abdominal pain, and skin rashes (e.g., maculopapular rash, urticaria). Serious and life-threatening adverse reactions, although rare, are officially documented and include:

  • Hypersensitivity: Severe and occasionally fatal anaphylactoid reactions, angioedema, and severe cutaneous adverse reactions (SCAR) such as Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute Generalized Exanthematous Pustulosis (AGEP).
  • Hepato-biliary Toxicity: Hepatitis and cholestatic jaundice, which can be severe and, in very rare circumstances, fatal. These effects may have a delayed onset of up to two months post-treatment.
  • Clostridium difficile-Associated Diarrhea (CDAD): Pseudomembranous colitis, which may occur during or several weeks after cessation of therapy.
  • Neurotoxicity: Myoclonia, convulsive seizures, and depressed consciousness, particularly when high serum concentrations are attained (e.g., in patients with renal failure or inflamed meninges).
  • Hematologic Reactions: Rare reports of leukopenia, neutropenia (including agranulocytosis), thrombocytopenia, and hemolytic anemia, which are typically reversible upon discontinuation.

Safety Restrictions and Monitoring

Cloxin is contraindicated in individuals with a known history of hypersensitivity to any penicillin, as cross-reactivity with cephalosporins is also possible.

Caution is advised when administering high doses, especially in the elderly and patients with impaired renal function, due to the increased risk of neurotoxicity and electrolyte imbalance. For prolonged or high-dose therapy, official guidelines recommend periodic monitoring of renal, hepatic, and hematopoietic functions.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Cloxin is officially documented as primarily causing symptoms of neurotoxicity. The regulatory prescribing information specifies manifestations such as convulsions (seizures), confusion, agitation, and signs of depressed consciousness. In severe cases, high concentrations of the drug may lead to progression toward coma and potential for death. Additionally, the official labeling notes a risk of nephrotoxicity (kidney damage) associated with high doses.

Overdose Risk Factors and Required Actions Official Regulatory Statement
Urgent Medical Help Required Contact a Poison Control Centre or hospital emergency department immediately, even if there are no symptoms.
Supportive Management Treatment is defined as strictly symptomatic and supportive, often requiring procedures like dialysis to promote drug excretion. No specific antidote is known.
Population-Specific Risks The potential for severe neurotoxicity is heightened in elderly patients and individuals with pre-existing impaired renal function. The immediate action upon confirmed or suspected overdose is to stop administration temporarily.

This profile emphasizes that the official required course of action is to seek emergency medical attention promptly due to the potential for severe, life-threatening CNS effects. The necessity of symptomatic treatment and renal monitoring structures the required hospital response.

Therapeutic Uses of Cloxin

Cloxin: Main Uses and Benefits

Cloxin is used to address infections caused by specific types of bacteria. It is commonly employed in clinical scenarios to help manage symptoms associated with bacterial infections of the skin and soft tissues, bones and joints, and the respiratory tract. It also serves as a supportive measure in more serious health concerns such as endocarditis (infection of the heart lining) and septicaemia (a form of blood infection).

The primary benefit for the patient is symptom relief and support for the body's efforts to clear the underlying infection. The selection of this medication is typically based on the organism's known susceptibility profile.

Cloxin is indicated for the treatment of infections due to penicillinase-producing staphylococci that are resistant to benzylpenicillin. This defines the use of the medication in managing infections caused by these specific organisms.


Quick Fact: Relief for Bacterial Infection Symptoms

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Cloxin

The eligibility profile for Cloxin (Cloxacillin) is defined by official regulatory documentation, which outlines absolute contraindications and population-specific restrictions for its use.


Eligibility Classification Population or Condition
Absolute Contraindication History of hypersensitivity to any penicillin or cephalosporin (due to cross-allergenicity).
Absolute Contraindication Neonates born of mothers with known penicillin hypersensitivity.
Conditional Use (Caution) Patients with impaired renal function or severe hepatic impairment.
Conditional Use (Caution) Patients with a history of atopic conditions (e.g., asthma, hay fever).

Age-Related Eligibility Status

Use is generally permitted in adults and adolescents. For children under one year of age, safety and efficacy may not be established in certain regulatory labels. Neonates require cautious administration and frequent monitoring of organ function due to limited experience and slower drug elimination.

Pregnancy and Lactation Eligibility

Cloxin is often classified as a Pregnancy Category B drug; therefore, use is recommended only if clearly needed and the potential necessity has been established. During breastfeeding, the medicine passes into breast milk, and official guidance suggests monitoring the infant for potential adverse effects, though they are considered unlikely to occur.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Cloxin, documented in government regulatory sources, identifies several clinically significant interactions structured by their effect on drug concentration or therapeutic activity. No specific timing-based administration rules or restrictions with food, alcohol, or herbal products are explicitly stated in the official interaction sections.

Exposure-Altering Interactions (Pharmacokinetic)

Interacting Substance Official Outcome Mechanism Statement
Probenecid Enhances the serum concentration of Cloxin. Inhibition of renal tubular secretion of Cloxin.
Methotrexate Cloxin increases the blood levels and effects of Methotrexate. Reduced renal clearance of Methotrexate.

Efficacy and Activity Interactions (Pharmacodynamic)

Interacting Substance Official Outcome/Restriction
Tetracycline/Erythromycin Co-administration is not suitable as it interferes with the bactericidal activity of Cloxin.
Warfarin ( Oral Anticoagulants) May increase the anticoagulant activities of these agents.
Oral Contraceptives Therapeutic efficacy of the contraceptive can be decreased.
Neuromuscular Blocking Agents May increase the neuromuscular blocking activities.
Live Bacterial Vaccines May interfere with vaccine effectiveness.

These interactions formally define Cloxin's profile through two core regulatory patterns: interference with renal clearance and alteration of pharmacodynamic response. The most significant restriction is the documented incompatibility with bacteriostatic antibiotics.

Mechanism of Action

How Cloxin Works: Targeting Bacterial Cell Integrity


Inhibition of Cell Wall Synthesis

Cloxin primarily acts within domains involving peptidoglycan synthesis, a vital structural component of the bacterial cell wall. The drug modifies early molecular steps by binding irreversibly to bacterial enzymes called Penicillin-Binding Proteins (PBPs) . This engagement blocks the final transpeptidation step, which is crucial for cross-linking the peptidoglycan strands and providing the wall's structural integrity.


Activation of Autolytic Cascades

The inhibition of PBPs and the resulting structural compromise initiates a mechanistic cascade involving the bacterial cell's own autolytic enzymes (autolysins). This modification of early molecular steps triggers the dysregulation and subsequent activation of autolysins, which proceed to degrade the already weakened cell wall. This sequence culminates in the lysis of the bacterial cell structure.


Beta-Lactamase Resistance Mechanism

Cloxin is relevant in systems where bacterial defenses, specifically β-lactamase enzymes, attempt to inactivate antibiotics. Due to a bulky substituent on its structure, the drug engages a resistance mechanism that confers resistance to hydrolysis by β-lactamase enzymes. This pathway effect reduces the rate of enzymatic breakdown, which permits the inhibition of PBPs and the subsequent collapse of the cell wall structure.

Dosage and Administration Information

How to Use Cloxin: Administration Principles

Cloxin administration involves specific routes, dose ranges, and schedule patterns. This section describes the high-level principles for its use.


Administration Scope Technical Parameters
Route of administration: Cloxin is used for Oral administration, available as hard capsules or solution, and for Parenteral administration via Intravenous (IV) or Intramuscular (IM) injection.
Dosing schedule: Adult Oral Dosing typically ranges from 250 mg to 500 mg per dose. Parenteral doses are usually 500 mg to 1 g, but may be increased up to 2 g per dose for severe infections, following established regimens.
Frequency and Timing: The standard dosing pattern requires administration every 6 hours (four times daily) for both oral and injectable forms. Oral doses are taken on an empty stomach, specifically 1 to 2 hours before meals or 2 hours after food.
Duration and Adjustment: The minimum required treatment duration is 5 days, with courses typically lasting 7 to 14 days. A high-level principle is the need for dose adjustment in patients with severe renal impairment (CrCl < 10 ml/min), often involving a reduced maintenance dose.
Preparation Principle: Parenteral forms are reconstituted and diluted for use; they should not be mixed with other medications in the same infusion container.

This framework establishes the parameters for drug use. It defines the administration route, the separation of oral intake from food to optimize absorption, and the frequency needed for sustained therapeutic presence. The principles also specify dosage modifications for individuals with reduced renal function.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cloxin

The body of research for Cloxin (cloxacillin) spans several decades and consists of foundational clinical research, large-scale observational studies, and modern randomized trials that often compare Cloxin to other agents. This overview summarizes what was observed in research conducted for its main uses, based only on official and peer-reviewed scientific sources.


Evidence for Use in Infections Due to Penicillinase-Producing Staphylococci

The core research for Cloxin was conducted to explore outcomes related to serious infections caused by specific strains of staphylococci (staph bacteria). Studies were conducted during periods of increased symptom activity and research examined outcomes related to systemic or functional imbalance caused by the infection.

Foundational research for Cloxin was primarily based on early clinical evaluations and later supported by large observational cohort studies. These studies monitored outcomes related to the body's reaction to the infection, specifically focusing on outcomes related to the absence of the target bacteria. The evidence contributes to the broader research landscape.

Studies report that Cloxin was studied for complex conditions such as infections of the heart lining (endocarditis), deep-seated bone and joint infections, and severe bloodstream infections (bacteremia). Reports describe Cloxin as having been an agent widely observed in research for these specific bacterial infections in the studied populations. Research highlights changes measured during the study period, particularly focusing on all-cause mortality and the incidence of infection recurrence.

Studies Focused on Serious Bloodstream Infections

Studies focusing on bloodstream infections have examined outcomes related to physiological strain or stress. These research efforts primarily used observational cohort studies to compare Cloxin's usage patterns and patient outcomes against those seen with other agents.

Findings from these observational studies research monitors patterns related to 90-day survival. Research contributes to understanding short-term changes, but certainty remains low because the evidence is often limited and heterogeneous, as is typical when comparing treatments using observational data rather than direct, randomized trials.


Comparison of Cloxin to Other Standard Antibiotics in Trials

Research has explored how Cloxin was observed in comparison to other agents studied for susceptible bacterial infections. Comparative evidence was evaluated in studies where two similar antibiotics were given to different patient groups to track their measured outcomes.

Comparative studies primarily focused on comparing Cloxin to first-generation cephalosporins, which are another class of agent studied for similar purposes. These trials assessed outcomes related to systemic or functional imbalance. Available data show patterns related to composite measured endpoints and often use endpoints like 90-day mortality and outcomes linked to physiological strain or stress. The research is ongoing, with dedicated Randomized Controlled Trials (RCTs) currently being conducted to confirm earlier findings and overcome the limitations of observational data.


Long-Term Studies and Follow-Up in Research

Research on Cloxin was studied for outcomes reflecting daily functioning or activity level. Due to the acute nature of the infections Cloxin is studied for, many studies focus on short-term outcomes related to symptom evolution. However, for more serious infections like bloodstream infections, follow-up durations are often intermediate and long-term, with the primary outcome measures often tracked up to 90 days post-treatment. This allows researchers to monitor measured indicators of infection status and to track outcomes related to infection recurrence.

Evidence for very long-term outcomes, particularly those related to the lasting nature of measured changes beyond the immediate post-treatment period, is limited. Few data are available for long-term changes. The research often focuses on immediate microbiological measurements and all-cause mortality.

Key Studies & References

  1. WHO Model List of Essential Medicines (Cloxacillin entry)
  2. Cloxacillin vs. Cefazolin in the Treatment of Staphylococcus aureus Bacteremia (CloCeBa): study protocol for a randomized controlled trial

Frequently Asked Questions (FAQ)

Common questions about Cloxin (FAQ)


Q: Are there any common foods or drinks that should be avoided while using Cloxin?

A: Official guidelines specify that the oral form should be taken on an empty stomach. The purpose of this timing is to prevent reduced absorption, which is the official reason for the timing guideline. Generally, this means taking the dose one to two hours before a meal or two hours after a meal.


Q: Does Cloxin have any impact on liver enzyme levels?

A: Regulatory documents report that Cloxin has the potential to cause adverse effects on the liver, including hepatitis and cholestatic jaundice. For patients receiving prolonged therapy, official guidelines recommend monitoring of liver function, which may involve checking enzyme levels.


Q: Can Cloxin be used by people who have mild kidney problems?

A: Caution is advised for individuals with existing kidney problems. Official guidelines indicate that specific dose adjustments are typically mandated only for those with severe renal impairment. The decision regarding use is a clinical one, based on the patient’s specific condition.


Q: Is there a different way Cloxin works for children compared to adults?

A: The official mechanism of action, which involves inhibiting bacterial cell wall synthesis, is described as the same across populations. Any differences in use between children and adults relate primarily to safety, dosing, and the rate at which the drug is eliminated from the body.


Q: What are the long-term safety considerations described for Cloxin?

A: For patients receiving prolonged Cloxin therapy, official guidelines recommend periodic monitoring of several body functions. This includes tracking renal function, hepatic function (liver), and hematopoietic (blood) counts to track relevant organ function during extended courses.


Q: Why is Cloxin sometimes preferred over other drugs for the same condition?

A: Cloxin is classified as a penicillinase-resistant penicillin. This means its unique chemical structure allows it to remain potent against certain bacterial strains that produce beta-lactamase enzymes. This resistance capability is the central feature that defines its clinical utility against these specific bacteria.


Q: Can Cloxin be used by older adults (over 65)?

A: Use in older adults is generally permitted according to official guidelines. However, caution is advised, especially when the patient is administered high doses. This caution is due to a potentially increased risk of certain side effects, such as neurotoxicity, in this age group.


Q: Does Cloxin interact with herbal supplements like St. John's Wort?

A: Official drug information includes a general warning that Cloxin may interact with certain herbal remedies or dietary supplements. For safety, official guidance recommends disclosing all non-prescription products to a healthcare professional.


Q: Can Cloxin be used long-term?

A: While typical treatment courses for Cloxin are short, the medication is prescribed for extended durations for serious infections like endocarditis or bone infections. Periodic monitoring of organ function is officially recommended for these extended courses.


Q: How does the effectiveness of Cloxin vary between different age groups?

A: Effectiveness is generally established for adults and adolescents. Official regulatory labels often note that safety and effectiveness may not be established in certain very young pediatric populations, such as children under one year of age.


Q: Does Cloxin affect cognitive function or memory?

A: Regulatory documents report the potential for neurotoxicity, which describes adverse effects on the nervous system. These effects, which include convulsive seizures and depressed consciousness, are typically associated with high drug concentrations in the body.


Q: What is the expiration date timeline for Cloxin, once dispensed?

A: The timeline depends on the drug's form. For example, the reconstituted oral solution should be discarded after 14 days if refrigerated, according to official storage guidance. The expiration date for the dry capsules or powder is typically printed on the container label provided by the pharmacy.


Q: Is Cloxin generally well-tolerated?

A: Official reports describe the majority of adverse effects associated with Cloxin as generally uncommon, mild, and transitory. However, the regulatory label also carries warnings about the potential for rare but serious or life-threatening reactions that require attention.


Q: Is Cloxin the same type of medicine as [similar drug name]? (General comparison)

A: Cloxin (Cloxacillin) is classified as an isoxazolyl penicillin, which is a specific class of antibiotic. This means it is chemically and pharmacologically related to other medicines in this group, such as oxacillin and dicloxacillin.


Q: How quickly does Cloxin usually start working for the average patient?

A: The medication is absorbed rapidly, and peak plasma concentrations are typically attained within one to two hours after an oral dose in fasting subjects. This rapid absorption allows the drug's effect to begin quickly.


Q: How long does Cloxin stay in the body after the last use?

A: Cloxacillin has a relatively short elimination half-life, which is officially reported as being around 30 minutes to 1 hour. This duration can be prolonged in certain circumstances, such as in individuals with renal impairment.


Q: Is it possible to become dependent on Cloxin?

A: Official information regarding Cloxin does not report any habit-forming tendencies. The medication is not classified as having the potential for dependence.


Q: What happens if a person stops using Cloxin suddenly?

A: Regulatory guidelines recommend that the entire prescribed course of medication be completed, even if symptoms begin to improve quickly. Stopping the medication prematurely risks therapeutic failure and may contribute to the development of drug-resistant bacteria.


Q: Does using Cloxin affect the results of common lab tests?

A: Official drug information indicates that Cloxin may interfere with certain laboratory tests. This interference includes some urine tests used to detect glucose (sugar), which could potentially lead to false test results.


Q: Are there any known interactions between Cloxin and common over-the-counter pain relievers?

A: Authoritative drug interaction databases report potential interactions with common compounds found in over-the-counter pain relievers. These may include Acetylsalicylic Acid (Aspirin) and Paracetamol (Acetaminophen) in some specific circumstances.


Q: Can Cloxin be split or crushed, or must it be used whole?

A: Regulatory patient counseling guidelines state that the capsules should not be broken, chewed, opened, or crushed. To ensure correct dosing and optimal absorption, the medication is generally directed to be swallowed whole.


Q: Are there generic versions of Cloxin available?

A: Yes, Cloxacillin is available as a generic drug. Regulatory labels for the medication are often issued under its generic name, Cloxacillin Sodium, reflecting its status.


Q: Is Cloxin a controlled substance?

A: No, Cloxacillin is not classified or scheduled as a controlled substance by major regulatory bodies in the United States or Canada.


Q: Is Cloxin metabolized by the liver?

A: Pharmacokinetic data confirms that Cloxacillin is partially processed, or metabolized, by the liver. The breakdown process results in the formation of both active and inactive metabolites.


Q: What is the difference between Cloxin and its active metabolite?

A: Cloxin is the parent drug compound. It is metabolized in the body into an inactive penicilloic acid metabolite and also, to a lesser extent, into an active metabolite. The parent compound, Cloxin, provides the primary therapeutic activity.


Q: Is it normal to feel a bit tired when first starting Cloxin?

A: The official side effect profile lists unusual tiredness as a potential adverse reaction that has been reported by some patients. This effect may be noticed when the therapy is first initiated.


Q: Is Cloxin commonly prescribed for animals?

A: Yes, Cloxacillin (cloxacillin benzathine) has official approval for use in veterinary medicine. It is approved by the FDA for treating specific infections, such as mastitis, in dairy cows during their dry period.


Q: What are the common conditions that Cloxin is used for in countries outside the US?

A: Cloxin is recognized globally as a systemic antibacterial agent by organizations like the WHO. The conditions it is used for in countries outside the US are generally consistent with its primary indication for treating susceptible staphylococcal infections worldwide.

How should Cloxin be stored and disposed of?

The storage and disposal of Cloxacillin (Cloxin) must adhere to specific regulatory requirements to maintain product stability and ensure public safety.


Storage Conditions

Dry Product (Capsules/Powder): Store at Controlled Room Temperature (below 25 C or 30 C). The container must be kept tightly closed and protected from light and moisture.

Reconstituted Oral Solution: This form requires storage in a refrigerator (2 C to 8 C) and must not be frozen. Any unused solution must be discarded after 14 days.


Disposal Requirements

All forms of the medication must be stored out of the sight and reach of children. Unused or expired Cloxacillin should not be flushed down the toilet or placed in household trash. Disposal should follow local and national regulatory requirements for medicinal product waste, typically through a drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cloxin found in:

A-Z Index: